Fmoc-2-Trifluoromethyl-D-Phenylalanine

Online Inquiry

CAT#CP16607
CAS352523-15-0
Synonyms/Alias352523-15-0;Fmoc-D-Phe(2-CF3)-OH;Fmoc-2-Trifluoromethyl-D-Phenylalanine;FMOC-D-2-TRIFLUOROMETHYLPHE;Fmoc-D-2-Trifluoromethylphenylalanine;Fmoc-2-(trifluoromethyl)-D-phenylalanine;(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoicacid;Fmoc-L-phe(2-CF3)-OH;(2R)-2-([(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO)-3-[2-(TRIFLUOROMETHYL)PHENYL]PROPANOICACID;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-[2-(trifluoromethyl)phenyl]propanoicacid;2-(Trifluoromethyl)-D-phenylalanine,N-FMOCprotected;47824_ALDRICH;SCHEMBL1409016;47824_FLUKA;ZINC2386920;1326AE;CF-647;PC8357;AKOS025312285;AB10299;AM83486;FMOCTRIFLUOROMETHYLPHENYLALANINE;FMOC-D-2-TRIFLUOROMETHYL-PHE-OH;AC-16851;AK188035
M.F/FormulaC25H20F3NO4
M.W/Mr.455.43
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 ICI 174,864 is an opioid peptide, belonging to subclasses of opioid receptors. Its chemical structure is N, N-di ...

 NoxA1ds is derived from a peptide whose structure is based on a short sequence of an essential Nox subunit. It b ...

  Fertirelin acetate, classified into peptide hormone, is a gonadotropin-releasing hormone (GnRH) antagonist or ...

Antioxidant effect of peptides  Peptides have been isolated from the resultant by-products in the past 15 years and suggested ...

 Compstatin is a 13-residue cyclic peptide (Ile1-Cys2-Val3-Val4-Gln5-Asp6-Trp7-Gly8-His9-His10-Arg11-Cys12-Thr13- ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.